This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
 NHF In The News
 NHF eNotes
 Medical Advisories
 Advocacy and Legislative Updates
-Medical News
 Blood Safety News
 NHF and Community News
 Industry News
 Travel Advisory



NHF Announces 2012 Clinical Fellowship Awardees

The National Hemophilia Foundation (NHF) is pleased to announce the recipients of the 2012 NHF-Baxter Clinical Fellowship. This year’s fellowship recipients are Tammuella Chrisentery-Singleton, MD, of Tulane University, and Jonathan Roberts, MD, of the Medical College of Wisconsin. 

Funded through the generous support of Baxter Healthcare Corporation, the NHF-Baxter Clinical Fellowship Program was developed to attract new physicians to the field of non-malignant hematology and further support their development as clinician-researchers. The goal of this program is to increase the number of physicians committed to a career in bleeding and clotting disorders by offering broad-based and quality mentored training from both a clinical and research perspective.  Fellows are nominated and subsequently selected from among 19 U.S. academic centers of excellence.  Decisions are made by an independent peer review panel of expert clinicians. 

Chrisentery-Singleton is Assistant Professor of Clinical Pediatrics at Tulane University and is board certified in pediatric hematology/oncology.  She will receive training under the mentorship of Cindy Leissinger, MD, Chief, Section of Hematology & Medical Oncology at Tulane University School of Medicine and Director of the Louisiana Center for Bleeding and Clotting Disorders.  

Chrisentery-Singleton graduated with honors from Xavier University, received her MD from Louisiana State University and then completed her pediatric residency at the University of Miami.  Following residency, she completed pediatric hematology/oncology fellowship training at Johns Hopkins University, where she worked with Dr. Jim Cassella and developed a serious interest in disorders of coagulation, particularly hemophilia. After her fellowship training, she was recruited to join the pediatric hematology/oncology faculty at LSU and Children’s Hospital of New Orleans.   

In 2010, Chrisentery-Singleton accepted a position at Tulane University because of her desire to receive more training and spend more time in the specialized coagulation medicine program.  As an NHF-Baxter Clinical Fellow, she will receive dedicated training in bleeding and clotting disorders for both children and adult patients, along with mentoring in clinical research related to bleeding disorders.  She will also continue her work on several ongoing clinical trials, and pursue her project in developing models to better determine pharmacokinetic parameters with a minimal number of needle sticks in pediatric patients with hemophilia.  Her goals are to steadily improve her knowledge and skills in caring for patients with coagulation disorders, and continue building her academic career in coagulation medicine. 

Dr. Jonathan Roberts is currently a pediatric hematology and oncology fellow with the Medical College of Wisconsin and the Children’s Hospital of Wisconsin.  His fellowship mentor will be Joan Gill, MD, Professor of Pediatrics at the Medical College of Wisconsin and Director of the Comprehensive Center for Bleeding Disorders (CCBD) at the BloodCenter of Wisconsin. 

Roberts graduated with honors from Greenville College, Illinois, and received his MD from Southern Illinois University School of Medicine.  He did his residency in Pediatrics at the University of Illinois at Peoria and Children’s Hospital of Illinois, where he also distinguished himself, receiving awards of excellence for critical care and research.   During his pediatric residency, Roberts worked with Dr. Michael Tarantino to initiate a clinical research trial to assess the role of FXIII on intraventricular hemorrhage in premature, low birth weight infants. 

As a NHF-Baxter Clinical Fellow, Roberts will receive focused training and gain clinical experience through the hemostasis clinics at CCBD and further develop his research skills in a project to develop a new ELISA-based assay for assigning VWF phenotype.  Roberts has plans to pursue a Master’s Degree in Clinical and Translational Science.  His goal is to become an expert physician/scientist with a long-term career focus on hemophilia, and other bleeding and clotting disorders.   

The NHF-Baxter Clinical Fellowship provides up to $100,000 annually to support up to two years of training at the fellow’s institution. Since the inception of this program in 2003, 23 fellows have been awarded this fellowship.  Many graduates of this program are already engaged in training other new hematology fellows and even successfully running bleeding and/or clotting treatment programs, as either medical directors or co-directors of centers.

Baxter’s generous sponsorship of this fellowship program will provide continued support of two additional fellows each year through 2014.

This section of our Web site is sponsored by: